Medical-grade skincare brand AlumierMD has appointed Daniel Hopkins as its new chief executive officer.

Hopkins has spent over a decade in the aesthetic sector including several roles in Allergan’s commercial functions and latterly the International Business Consulting Group, supporting the strategic development of services in the EMEA and APAC regions, explains the company.

Hopkins joined AlumierMD four years ago as managing director for its European operations and plans to help grow the company in its next phase, adds AlumierMD.

Hopkins commented, “We are incredibly proud of what we have been able to achieve at AlumierMD in a relatively short period of time. I am both proud and excited to lead an incredible group of innovators to empower our sector, creating exceptional patient outcomes at every step of the journey.”

SOURCEAesthetics Journal
Previous articleSofwave cellulite technology receives FDA clearance
Next articleAllergan Aesthetics takes a 360°approach to non-surgical aesthetic treatments to improve patient outcomes with expert-led medical education symposium at IMCAS 2023